Drug interactions
Nicardipine + Ponatinib
Severity: Moderate
Nicardipine and Ponatinib: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ponatinib is metabolized by CYP3A4, and nicardipine may modestly raise its levels. Higher ponatinib exposure could worsen hypertension, pancreatitis, hepatotoxicity and vascular occlusion risk.
What this interaction means in plain words
Nicardipine and Ponatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Nicardipine belongs to Cardiovascular; Ponatinib belongs to Oncology.
Why it happens
Nicardipine weakly inhibits CYP3A4, reducing ponatinib metabolism.
What to do
Monitor blood pressure and for ponatinib toxicity; dose reduction is advised mainly with strong inhibitors. Adjust the antihypertensive regimen as needed.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Nicardipine and Ponatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Nicardipine
Other interactions of Ponatinib
Frequently asked questions
Can I take Nicardipine with Ponatinib?
MediHelp rates the interaction as moderate. Nicardipine and Ponatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ponatinib is metabolized by CYP3A4, and nicardipine may modestly raise its levels. Higher ponatinib exposure could worsen hypertension, pancreatitis, hepatotoxicity and vascular occlusion risk.
How serious is the interaction between Nicardipine and Ponatinib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and for ponatinib toxicity; dose reduction is advised mainly with strong inhibitors. Adjust the antihypertensive regimen as needed.
What other medicines interact with Nicardipine?
MediHelp also lists interactions of Nicardipine with, for example, Amifostine, Amlodipine-olmesartan-hydrochlorothiazide, Betrixaban. The full list is on the Nicardipine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
